Change in Fibrosis-4 Index (FIB4) is associated with risk of liver events, cardiovascular events, and all-cause mortality in patients with obesity and/or type 2 diabetes (T2D)
Authors:
Kamlesh Khunti1; Tina L. Berentzen2; Louise M. Nitze2; Maximilian Jara2; Anders Jensen2; Mette S. Kjær2; Kamal K. Mangla2; Jens M. Tarp2; Quentin Anstee3,4